Cargando…

The Possible Role of Flavonoids in the Prevention of Diabetic Complications

Type 2 diabetes mellitus is a disease that affects many metabolic pathways. It is associated with insulin resistance, impaired insulin signaling, β-cell dysfunction, abnormal glucose levels, altered lipid metabolism, sub-clinical inflammation and increased oxidative stress. These and other unknown m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Testa, Roberto, Bonfigli, Anna Rita, Genovese, Stefano, De Nigris, Valeria, Ceriello, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882722/ https://www.ncbi.nlm.nih.gov/pubmed/27213445 http://dx.doi.org/10.3390/nu8050310

Ejemplares similares

The “Metabolic Memory” Theory and the Early Treatment of Hyperglycemia in Prevention of Diabetic Complications
por: Testa, Roberto, et al.
Publicado: (2017)

Oscillating glucose induces microRNA-185 and impairs an efficient antioxidant response in human endothelial cells
por: La Sala, Lucia, et al.
Publicado: (2016)

GLP-1 reduces metalloproteinase-9 induced by both hyperglycemia and hypoglycemia in type 1 diabetes. The possible role of oxidative stress
por: Ceriello, Antonio, et al.
Publicado: (2015)

The Possible Protective Role of Glucagon-Like Peptide 1 on Endothelium During the Meal and Evidence for an “Endothelial Resistance” to Glucagon-Like Peptide 1 in Diabetes
por: Ceriello, Antonio, et al.
Publicado: (2011)

Short-term high glucose exposure impairs insulin signaling in endothelial cells
por: De Nigris, Valeria, et al.
Publicado: (2015)

The protective effect of the Mediterranean diet on endothelial resistance to GLP-1 in type 2 diabetes: a preliminary report
por: Ceriello, Antonio, et al.
Publicado: (2014)

N-Glycomic Changes in Serum Proteins in Type 2 Diabetes Mellitus Correlate with Complications and with Metabolic Syndrome Parameters
por: Testa, Roberto, et al.
Publicado: (2015)

Evidences of +896 A/G TLR4 Polymorphism as an Indicative of Prevalence of Complications in T2DM Patients
por: Balistreri, Carmela Rita, et al.
Publicado: (2014)

The dipeptidyl peptidase-4 (DPP-4) inhibitor teneligliptin functions as antioxidant on human endothelial cells exposed to chronic hyperglycemia and metabolic high-glucose memory
por: Pujadas, Gemma, et al.
Publicado: (2016)

Evidence That Hyperglycemia After Recovery From Hypoglycemia Worsens Endothelial Function and Increases Oxidative Stress and Inflammation in Healthy Control Subjects and Subjects With Type 1 Diabetes
por: Ceriello, Antonio, et al.
Publicado: (2012)

Diabetes, D-dimer and COVID-19: The possible role of glucose control
por: Ceriello, Antonio
Publicado: (2020)

Extracellular vesicle-shuttled miRNAs: a critical appraisal of their potential as nano-diagnostics and nano-therapeutics in type 2 diabetes mellitus and its cardiovascular complications
por: Prattichizzo, Francesco, et al.
Publicado: (2021)

Mitochondrial DNA Backgrounds Might Modulate Diabetes Complications Rather than T2DM as a Whole
por: Achilli, Alessandro, et al.
Publicado: (2011)

DPP-4 Inhibitors Have Different Effects on Endothelial Low-Grade Inflammation and on the M1-M2 Macrophage Polarization Under Hyperglycemic Conditions
por: De Nigris, Valeria, et al.
Publicado: (2021)

Antioxidant Anti-Inflammatory Treatment in Type 2 Diabetes
por: Ceriello, Antonio, et al.
Publicado: (2009)

“Inflammaging” as a Druggable Target: A Senescence-Associated Secretory Phenotype—Centered View of Type 2 Diabetes
por: Prattichizzo, Francesco, et al.
Publicado: (2016)

A Review of the Long-Term Efficacy, Tolerability, and Safety of Exenatide Once Weekly for Type 2 Diabetes
por: Genovese, Stefano, et al.
Publicado: (2017)

Glucagon and heart in type 2 diabetes: new perspectives
por: Ceriello, Antonio, et al.
Publicado: (2016)

Genes associated with Type 2 Diabetes and vascular complications
por: Montesanto, Alberto, et al.
Publicado: (2018)

The Unique Pharmacological and Pharmacokinetic Profile of Teneligliptin: Implications for Clinical Practice
por: Ceriello, Antonio, et al.
Publicado: (2019)

Centenarians as super-controls to assess the biological relevance of genetic risk factors for common age-related diseases: A proof of principle on type 2 diabetes
por: Garagnani, Paolo, et al.
Publicado: (2013)

Epigenetic mechanisms of endothelial dysfunction in type 2 diabetes
por: Prattichizzo, Francesco, et al.
Publicado: (2015)

Variability of risk factors and diabetes complications
por: Ceriello, Antonio, et al.
Publicado: (2021)

The Genetic Variability of Members of the SLC38 Family of Amino Acid Transporters (SLC38A3, SLC38A7 and SLC38A9) Affects Susceptibility to Type 2 Diabetes and Vascular Complications
por: Crocco, Paolina, et al.
Publicado: (2022)

Teneligliptin enhances the beneficial effects of GLP-1 in endothelial cells exposed to hyperglycemic conditions
por: De Nigris, Valeria, et al.
Publicado: (2017)

Type 1 diabetes and cardiovascular disease
por: Schnell, Oliver, et al.
Publicado: (2013)

Extracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity?
por: Prattichizzo, F., et al.
Publicado: (2016)

The Coming Age of Flavonoids in the Treatment of Diabetic Complications
por: Caro-Ordieres, Teresa, et al.
Publicado: (2020)

Age- and glycemia-related miR-126-3p levels in plasma and endothelial cells
por: Olivieri, Fabiola, et al.
Publicado: (2014)

Short-term sustained hyperglycaemia fosters an archetypal senescence-associated secretory phenotype in endothelial cells and macrophages
por: Prattichizzo, Francesco, et al.
Publicado: (2017)

Cardiovascular guidelines: separate career may help attenuate controversy
por: Esposito, Katherine, et al.
Publicado: (2014)

Predictors of chronic kidney disease in type 1 diabetes: a longitudinal study from the AMD Annals initiative
por: Piscitelli, Pamela, et al.
Publicado: (2017)

MiR-21-5p and miR-126a-3p levels in plasma and circulating angiogenic cells: relationship with type 2 diabetes complications
por: Olivieri, Fabiola, et al.
Publicado: (2015)

Publisher Correction: Predictors of chronic kidney disease in type 1 diabetes: a longitudinal study from the AMD Annals initiative
por: Piscitelli, Pamela, et al.
Publicado: (2018)

Flavonoids and Their Metabolites: Prevention in Cardiovascular Diseases and Diabetes
por: Zeka, Keti, et al.
Publicado: (2017)

Comparison Review of Short-Acting and Long-Acting Glucagon-like Peptide-1 Receptor Agonists
por: Uccellatore, Annachiara, et al.
Publicado: (2015)

Control of Reactive Oxygen Species for the Prevention of Parkinson’s Disease: The Possible Application of Flavonoids
por: Kim, Tae Yeon, et al.
Publicado: (2020)

Glucagon-Like Peptide 1 Reduces Endothelial Dysfunction, Inflammation, and Oxidative Stress Induced by Both Hyperglycemia and Hypoglycemia in Type 1 Diabetes
por: Ceriello, Antonio, et al.
Publicado: (2013)

Report from the 1st Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group
por: Schnell, Oliver, et al.
Publicado: (2016)

Antioxidant, antiglycation and insulinotrophic properties of Coccinia grandis (L.) in vitro: Possible role in prevention of diabetic complications
por: Meenatchi, Packirisamy, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3nvf9h01mcfbbbidd2fi9nr3nk